A healthcare focused venture capital firm based in China, with offices in Shanghai and Beijing, makes venture investments in early and growth stage companies and occasionally invests in PIPE deals. The firm recently raised a USD 300 million fund in 2014. The firm is flexible regarding the investment size; the firm can invest anywhere from several hundred thousand dollars up to USD 10 million or more. The firm generally invests in Chinese companies but will look at opportunities from around the world. The firm is actively seeking new investment opportunities.
The firm invests opportunistically in the life sciences. The firm is interested in biopharmaceuticals, medical devices, diagnostics, and mobile/digital health. For therapeutics, the firm considers all molecules and biologics, including biosimiliars and reformulated drugs. In terms of stage of development, the firm looks for products in early to late stages of clinical trials. For medical devices, the firm considers all classes of devices and generally looks for devices in later stages of development or close to market.
The firm invests in both private and public companies.
If you are interested in more information about this investor and other investors tracked by LSN, please email firstname.lastname@example.org